Improvements in insulin sensitivity with tirzepatide versus semaglutide

被引:0
|
作者
Kahl, S. [1 ]
机构
[1] Heinrich Heine Univ, Inst Klin Diabetol, Deutsch Diabet Zentrum, Leibniz Zentrum Diabet Forsch, Hennekamp 65, D-40225 Dusseldorf, Germany
来源
DIABETOLOGIE | 2025年 / 21卷 / 02期
关键词
D O I
10.1007/s11428-025-01294-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:221 / 222
页数:2
相关论文
共 50 条
  • [31] Ozempic v Mounjaro: what is the difference between semaglutide and tirzepatide?
    Lang, Katharine
    BMJ-BRITISH MEDICAL JOURNAL, 2025, 388
  • [32] Comparison of different doses of tirzepatide and semaglutide in type 2 diabetes
    Kahl, S.
    DIABETOLOGIE, 2022, 18 (06): : 756 - 757
  • [33] MECHANISMS OF ACTION OF TIRZEPATIDE IN HUMANS: BETA AND ALPHA CELLS EFFECTS AND INSULIN SENSITIVITY
    Mari, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A13 - A13
  • [34] At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide
    Ruder, Kate
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (01): : 9 - 11
  • [35] Tirzepatide Improved Markers of Islet Cell Function (Fasting Glucagon and HOMA2-B) and Insulin Sensitivity (Fasting Insulin and HOMA2-IR) Compared to Semaglutide in People with Type 2 Diabetes
    Brown, Katelyn
    Lando, Laura Fernandez
    Bergman, Brandon
    Thomas, Melissa K.
    Liu, Bing
    Lee, Clare
    Giebel, Amanda M.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 153
  • [36] Real-world effectiveness of tirzepatide versus semaglutide for weight loss in overweight or obese patients in an ambulatory care setting
    Trinh, Huong
    Donovan, Anthony
    McAdam-Marx, Carrie
    DIABETES OBESITY & METABOLISM, 2025,
  • [37] How do tirzepatide and semaglutide compare for weight loss ... and other research
    Nolan, Tom
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 386
  • [38] Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice
    Lv, Fang
    Cai, Xiaoling
    Lin, Chu
    Yang, Wenjia
    Ji, Linong
    PHARMACEUTICALS, 2024, 17 (12)
  • [39] Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 Diabetes
    Snell-Bergeon, Janet K.
    Kaur, Gurleen
    Renner, Drew
    Akturk, Halis K.
    Beatson, Christie
    Garg, Satish K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2025, 27 (01) : 1 - 9
  • [40] Tirzepatide Improved Markers of Islet-Cell Function (Fasting Glucagon and HOMA2-B) and Insulin Sensitivity (Fasting Insulin and HOMA2-IR) Compared with Semaglutide in People with Type 2 Diabetes
    Brown, Katelyn
    Lando, Laura Fernandez
    Bergman, Brandon
    Thomas, Melissa K.
    Liu, Bing
    Lee, Clare
    DIABETES, 2022, 71